Yuma Kujime
Papers
1
Total Citations
4
H-Index
1
About
Dr. Yuma Kujime is a clinician-researcher whose work centers on the intersection of urologic oncology and skeletal health, with a particular focus on the adverse effects of cancer therapies. His most prominent contribution addresses the critical issue of fragility fracture risk in patients with prostate cancer. In a landmark 2024 study, Dr. Kujime employed quantitative computed tomography to precisely measure lumbar spine bone loss in a propensity-matched cohort, demonstrating the significant negative impact of androgen deprivation therapy (ADT) on bone density. This work, which has already garnered 4 citations, provides essential, objective data for clinicians managing the long-term skeletal consequences of hormone therapy. By moving beyond traditional DXA scans to more accurate volumetric bone assessment, Dr. Kujime’s research offers a more nuanced understanding of treatment-related morbidity, directly informing strategies for fracture prevention and bone health monitoring in prostate cancer survivors.
Research Focus
Key Achievements
Top Papers
- 1